 Connection
Kenneth Tyler to Leukoencephalopathy, Progressive Multifocal
This is a "connection" page, showing publications Kenneth Tyler has written about Leukoencephalopathy, Progressive Multifocal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.188 |
|
|
|
-
Clifford DB, Tyler KL. Dosing interval of natalizumab in MS: Do good things come to those who wait? Neurology. 2019 10 08; 93(15):655-656.
Score: 0.651
-
Tyler KL, Vollmer TL. To PLEX or not to PLEX in natalizumab-associated PML. Neurology. 2017 03 21; 88(12):1108-1109.
Score: 0.546
-
Tyler KL. PML therapy: "It's D?j? vu all over again". J Neurovirol. 2013 Aug; 19(4):311-3.
Score: 0.426
-
Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol. 2011 Sep; 68(9):1156-64.
Score: 0.365
-
Tyler KL. Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Ann Neurol. 2010 Sep; 68(3):271-4.
Score: 0.348
-
Tyler KL. Emerging viral infections of the central nervous system: part 2. Arch Neurol. 2009 Sep; 66(9):1065-74.
Score: 0.325
-
Tyler KL. The 50th birthday of progressive multifocal leukoencephalopathy: New insights into pathogenesis. Ann Neurol. 2008 Oct; 64(4):359-61.
Score: 0.305
-
Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005 Jul 28; 353(4):369-74.
Score: 0.242
-
Tyler KL, Khalili K. Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. Rev Neurol Dis. 2005; 2(3):144-9.
Score: 0.235
-
Tyler KL. The uninvited guest: JC virus infection of neurons in PML. Neurology. 2003 Sep 23; 61(6):734-5.
Score: 0.215
-
Richardson-Burns SM, Kleinschmidt-DeMasters BK, DeBiasi RL, Tyler KL. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol. 2002 Dec; 59(12):1930-6.
Score: 0.204
-
Patera AC, Butler SL, Cinque P, Clifford DB, Elston R, Garcea RL, Major EO, Pavlovic D, Peterson IS, Ryan AM, Tyler KL, Weber T. 2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment. J Neurovirol. 2015 Dec; 21(6):702-5.
Score: 0.125
-
Korman BD, Tyler KL, Korman NJ. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol. 2009 Aug; 145(8):937-42.
Score: 0.081
-
Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol. 2009 May; 66(5):593-9.
Score: 0.079
-
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology. 1999 Feb; 52(3):623-5.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|